In contrast, such progress is lacking for other tauopathies classified as FTLD-tau, including CBD, PSP, argyrophilic grain disease (AGD), globular glial tauopathy, chronic traumatic encephalopathy (CTE) and Pick’s disease (PiD). This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.